Clinic
Chase Brexton Health Services, INC.
Chase Brexton Health Services, INC. was paid $87.22M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 48% of everything it billed.
33Billing provider infoCHASE BREXTON HEALTH SERVICES, INC.
BALTIMORE, MD 21201
BALTIMORE, MD 21201
33aNPI1588606305assigned 06/13/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$87.22M
24GClaims503,602
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Maryland
Rank by total paid#3 of 34
Median peer was paid$741K
This provider vs. median118×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,654 | $2.72M | |
| 2019 | 23,537 | $3.85M | |
| 2020 | 68,998 | $14.19M | |
| 2021 | 115,770 | $16.23M | |
| 2022 | 90,336 | $16.72M | |
| 2023 | 98,044 | $17.61M | |
| 2024incomplete | 92,263 | $15.90M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 48% | 170,345 | 100,875 | $42.19M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 94,508 | 81,372 | $23.96M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 59,846 | 53,426 | $15.20M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 5,282 | 4,726 | $1.30M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.2% | 3,561 | 3,303 | $1.01M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 3,400 | 2,998 | $950K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 1,899 | 1,032 | $574K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,551 | 1,459 | $447K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 911 | 871 | $272K |
| 97803 | <1% | 1,415 | 1,093 | $265K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 554 | 490 | $154K |
| 90677 | <1% | 1,005 | 787 | $112K |
100 more codes
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 384 | $105K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 250 | $59K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 200 | $53K |
| 3074F | <1% | 21,092 | $46K | |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | <1% | 188 | $46K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 891 | $39K |
| 3078F | <1% | 17,054 | $33K | |
| 0011A | <1% | 956 | $33K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 113 | $32K |
| 59430 | <1% | 160 | $31K | |
| 3008F | <1% | 25,299 | $27K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 544 | $26K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,097 | $24K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 94 | $24K |
| 0012A | <1% | 627 | $21K | |
| 97802 | <1% | 187 | $19K | |
| 3079F | <1% | 7,761 | $18K | |
| 90651 | <1% | 295 | $17K | |
| 90670 | <1% | 1,749 | $17K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13,064 | $16K |
| 99383 | <1% | 38 | $12K | |
| 99381 | <1% | 34 | $10K | |
| 90686 | <1% | 4,930 | $9K | |
| 90648 | <1% | 2,498 | $8K | |
| 36416 | <1% | 259 | $7K | |
| 3077F | <1% | 2,275 | $6K | |
| 3048F | <1% | 174 | $6K | |
| 1036F | <1% | 5,280 | $5K | |
| 3075F | <1% | 1,711 | $5K | |
| 0134A | <1% | 187 | $5K | |
| G0467 | Community health center visit, returning patient | <1% | 8,311 | $5K |
| 90715 | <1% | 376 | $4K | |
| 3080F | <1% | 1,067 | $3K | |
| 0500F | <1% | 220 | $3K | |
| S0316 | Disease management program, follow-up/reassessment | <1% | 93 | $2K |
| 90723 | <1% | 1,830 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 120 | $2K |
| 0071A | <1% | 55 | $2K | |
| 0503F | <1% | 79 | $2K | |
| 0072A | <1% | 32 | $1K | |
| 81002 | <1% | 252 | $1K | |
| 3500F | <1% | 1,640 | $1K | |
| 92551 | <1% | 3,148 | $1K | |
| 0064A | <1% | 24 | $800.52 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,183 | $795.57 |
| 90680 | <1% | 1,173 | $675.55 | |
| 91301 | <1% | 1,217 | $596.18 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 239 | $506.55 |
| 3046F | <1% | 80 | $468.09 | |
| 3044F | <1% | 126 | $464.35 | |
| 90474 | <1% | 941 | $432.00 | |
| 90633 | <1% | 703 | $293.39 | |
| 90661 | <1% | 111 | $288.72 | |
| 90734 | <1% | 70 | $280.40 | |
| 99459 | <1% | 312 | $226.56 | |
| 90656 | <1% | 859 | $218.30 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 142 | $214.96 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 1,322 | $210.79 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 4,325 | $191.22 |
| 90619 | <1% | 26 | $186.24 | |
| 93000 | <1% | 126 | $181.51 | |
| 99177 | <1% | 684 | $151.20 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 337 | $123.75 |
| 90653 | <1% | 25 | $35.89 | |
| 90710 | <1% | 282 | $23.28 | |
| 96127 | <1% | 640 | $20.26 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 98 | $8.72 |
| 4145F | 0% | 502 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 4,297 | $0.00 |
| 90461 | 0% | 1,475 | $0.00 | |
| 99173 | 0% | 2,384 | $0.00 | |
| 4274F | 0% | 575 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 39 | $0.00 |
| 4040F | 0% | 663 | $0.00 | |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | 0% | 1,371 | $0.00 |
| 91313 | 0% | 104 | $0.00 | |
| 83655 | 0% | 113 | $0.00 | |
| 87210 | 0% | 15 | $0.00 | |
| 81025 | 0% | 83 | $0.00 | |
| 80305 | 0% | 58 | $0.00 | |
| 1160F | 0% | 28 | $0.00 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 75 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 14 | $0.00 |
| 90750 | 0% | 18 | $0.00 | |
| 90707 | 0% | 27 | $0.00 | |
| 91300 | 0% | 19 | $0.00 | |
| 4010F | 0% | 3,248 | $0.00 | |
| 2000F | 0% | 940 | $0.00 | |
| 90694 | 0% | 108 | $0.00 | |
| H0038 | Self-help/peer services, per 15 minutes | 0% | 70 | $0.00 |
| 91307 | 0% | 128 | $0.00 | |
| 85018 | 0% | 130 | $0.00 | |
| 90696 | 0% | 30 | $0.00 | |
| G8708 | Patient not prescribed antibiotic | 0% | 14 | $0.00 |
| 90674 | 0% | 22 | $0.00 | |
| INVCD | 0% | 29 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 15 | $0.00 |
| 4149F | 0% | 25 | $0.00 | |
| 90716 | 0% | 27 | $0.00 | |
| 91306 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEASTON, KYLE (REVENUE CYCLE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Chase Brexton Health Services, INC. | Baltimore, MD | $2.31M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.